Do you actually need both Selank and Dihexa

Ever stack two peptides in your protocol just because they showed up on the same forum thread? Selank and Dihexa get lumped together as "cognitive peptides," but they are NOT cousins, and they are definitely NOT a matched pair. Short answer: no, you don't need both Selank and Dihexa, because they solve two completely different problems, and right now only one of them has real evidence standing behind it.

What each one is actually trying to do

Selank calms your nervous system down. Dihexa is supposed to build brand new wiring in your brain. Different jobs. Not overlapping ones.

Selank is a Russian-developed anxiolytic peptide, approved in Russia for generalized anxiety disorder, that works through a triple pathway: it boosts BDNF (the protein your brain uses to grow and repair itself), it slows the breakdown of your own natural opioids, and it recalibrates how your serotonin and dopamine systems respond. No sedation. No cognitive fog. NOTHING clouding your head the next morning. That's the whole reason folks reach for it over a benzodiazepine.

Dihexa is chasing something completely different: synaptogenesis, meaning it's supposed to physically grow new connection-and-wiring stuff between neurons. Big claim. HUGE claim, honestly. The pitch has always been "the most potent nootropic ever discovered."

Here's the thing nobody tells you upfront: chasing Dihexa's big promise before you've handled the basics is like hanging crown moldings on a house with no foundation poured yet. Looks great in the brochure. Falls in on itself the first time it's tested. If your actual problem is anxiety, rumination, or a brain that won't shut off at 11pm, you don't need speculative synapse-building. You need the calming tool that's already proven itself in real patients.

The evidence gap that changes everything

This is where the two peptides stop being comparable at all. Selank has been through multiple controlled human trials, including a head-to-head against an actual prescription anti-anxiety drug, and it matched the relief without the sedation hangover or the slowed reaction time. In a second trial against a different benzodiazepine, Selank came out ahead on tolerability while holding the same anxiolytic punch. Over 800 patients, across a decade-plus of Russian clinical use. That's a real, hugely reassuring evidence base, not a forum rumor.

Dihexa's entire mechanism claim traces back to one foundational paper. That paper got RETRACTED in 2025. Not "under review." Not "awaiting further data." Retracted. Every peptide forum still repeating the "seven orders of magnitude more potent than BDNF" line is quoting a study that no longer stands. Zero completed human trials exist for Dihexa. NONE. I checked, and there just aren't any, which is a hell of a gap for something marketed as a top-tier nootropic.

I'm a proud geek about mechanism papers, so when one gets retracted, I go read the actual retraction notice instead of just trusting the headline someone else wrote. I've also had people ask me if Dihexa is the next BPC-157, something that'll eventually build up decades of trust the same way. I get why they ask, it's a fair question. But BPC-157 has years of documented use and a genuinely boring safety record behind it. Dihexa has a retracted mechanism paper and a research-chemical listing. Those are VASTLY different starting lines, and pretending otherwise doesn't help anybody make a good decision.

Cost, side effects, and who each one actually fits

Selank's side-effect list is short and frankly kind of boring: mild nasal irritation from the spray, an occasional first-week headache, and that's about it. No hepatotoxicity. No dependence pattern. No withdrawal. It's one of the cleanest safety profiles in the whole peptide catalog, and it plays fine alongside a TRT protocol if that's part of your stack too.

Dihexa's safety database is essentially empty. There's a theoretical worry worth taking seriously, too: the HGF/c-Met pathway it's supposed to work through is also a driver in several cancers, which is exactly why anyone with a personal or family cancer history should treat this as a hard no. That's not fear for fear's sake, that's just the honest truth about where the science stands right now.

Availability tracks the evidence, which tells you something on its own. Selank is easy to find from a vetted source, US Pure Peptides carries it, code OHM20 knocks 20% off. Dihexa isn't carried by any of OHM's affiliate vendors at all right now, precisely because the retraction and the empty safety record don't clear the bar. Heads up, and I'll be straight about this too: OHM has an affiliate relationship with the vendors linked here, so we earn a commission if you buy through one of these links. It costs you nothing extra and it does not change which peptide the evidence actually supports.

If you want to go deeper on either one before deciding, the full write-ups are here: Selank and Dihexa. Worth a read before you spend money on either, especially if you're newer to the space, and this piece on peptide safety in general is a good companion read too.

So, do you actually need both?

For most people, nope. If anxiety, rumination, or a noisy brain at night is the actual target, Selank is the tool with the trial data to back it up. Dihexa's synaptogenesis story might turn out to be real someday, but "someday" is doing a lot of work in that sentence, and this is a marathon, not a sprint, for the research to catch back up to the hype. That's a hugely different bet than the one you're making with Selank.

Now the part my lawyer makes me say, and honestly he's right:

The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

For Selank, the community-standard protocol is 300 to 600 mcg a day, split into 2 to 3 intranasal doses, run 14 days on and 7 off. No dose creep needed. Trial data showed the same dose held its effect all the way through day 28.

For Dihexa, the numbers floating around forums are 8 to 45 mg a day orally, or 2 to 5 mg a day subcutaneously, with no validated cycle length at all. When nobody's actually validated a cycle, that means your body is running the experiment, not a protocol.

Selank has earned its spot in a stack. Dihexa, right now, is a bet on a mechanism paper that already fell apart once. You don't need both. You need the one that's already proven what it says it does.

Thanks for reading! In health, Rick Gold